戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rgery on patients with primary and recurrent pterygium.
2 rygium, but scarce from those with recurrent pterygium.
3 eoplasia is uncommonly found to coexist with pterygium.
4 on patterns of HCC in normal conjunctiva and pterygium.
5 pemphigoid, vernal keratoconjunctivitis, and pterygium.
6 rials reporting on surgical intervention for pterygium.
7 lone in most studies of primary or recurrent pterygium.
8 recurrence rate after surgical excision of a pterygium.
9 examine the anterior segment for evidence of pterygium.
10      Eighty-nine adult patients with primary pterygium.
11 vel (P<0.001) as significant factors for any pterygium.
12 he relationship of race and other factors to pterygium.
13 were identified as contributing to childhood pterygium.
14  with amniotic membrane transplant (AMT) for pterygium.
15 nical behavior between primary and recurrent pterygium.
16 on (38%) histological diagnosis, followed by pterygium (36%) and actinic keratosis (19%).
17 contributed significantly to presence of any pterygium (41%; P<0.001) or presence in both eyes (33%;
18 ignificant difference in recurrence rates of pterygium after surgery with mitomycin C application bet
19 of resources, primary or recurrent status of pterygium, age of patient, and surgeon or patient prefer
20 l was further elevated in patients with both pterygium and demodicosis (all P<0.05).
21 e of 16 years, consecutively presenting with pterygium and evaluated at a single tertiary care center
22 ents were divided into the following groups: pterygium and no OSSN (group 1), clinically suspected OS
23  biological samples taken from patients with pterygium and normal volunteers, whom were operated unde
24 have clinical implications on progression of pterygium and recurrence associated with incomplete exci
25 with several external eye diseases including pterygium and squamous metaplasia or carcinoma.
26           Any type of eye surgery, extensive pterygium, and lack of cooperation were used as exclusio
27 SSN mirrors that of OSSN not associated with pterygium, and thus vigilance for recurrence is importan
28 n, classification of pterygium, width of the pterygium at limbus, surgical technique (conjunctival au
29  added at 10 ng/ml to early passaged primary pterygium body fibroblasts (PBF) or normal human conjunc
30 data is available from patients with primary pterygium, but scarce from those with recurrent pterygiu
31 s of HCC mRNAs and proteins were detected in pterygium compared with a normal conjunctiva.
32                     All the eyes had primary pterygium, except 1, which was recurrent.
33  in place of conjunctival autografting after pterygium excision and to reconstruct the conjunctival s
34  C further reduces the recurrence rate after pterygium excision compared with conjunctival or limbal
35                           All eyes underwent pterygium excision followed by removal of subconjunctiva
36 ry during conjunctival transplantation after pterygium excision have not been answered fully.
37 al autografts or mitomycin C during or after pterygium excision reduced recurrence compared with bare
38 ust 2007, consecutive subjects indicated for pterygium excision were enrolled from an outpatient eye
39      Four eyes (15%) required surgery, where pterygium excision with conjunctival-limbal autograft wi
40                       All patients underwent pterygium extended removal followed by extended conjunct
41                                              Pterygium extended removal followed by extended conjunct
42          Simple excision or resection of the pterygium followed by conjunctival autografting or intra
43 terygium (group 2), and unexpected OSSN with pterygium found on histopathology (group 3).
44 pared to the control group, in the recurrent pterygium group there was a significant decrease in the
45 ompared to the control group, in the primary pterygium group there was an increase in NO and TAS, and
46 s within the control group and the recurrent pterygium group, but not within the primary pterygium gr
47 inished antioxidant defense in the recurrent pterygium group, possibly determined mainly by decreased
48  pterygium group, but not within the primary pterygium group.
49 el and low TAS level of women in the prymary pterygium group.
50 SN (group 1), clinically suspected OSSN with pterygium (group 2), and unexpected OSSN with pterygium
51        The primary outcome was recurrence of pterygium &gt;/=1 mm onto the cornea by 3 and 6 months post
52                                              Pterygium is a disorder of the ocular surface induced by
53                               Development of pterygium is a possibility in younger age groups.
54                                              Pterygium is an important illness that affects 22% peopl
55                     Tears from patients with pterygium (n = 50) and normal volunteers (n = 24) were o
56 significantly higher in patients with either pterygium or demodicosis than controls (P = 0.049 and 0.
57  defect to cover as in primary double-headed pterygium, or in the context of preserving superior bulb
58  recurrent pterygium than those with primary pterygium (P = 0.015).
59 ients (6.9%) in the LCAU group had recurrent pterygium (P = 0.021).
60 tuted 7.4% of primary and 12.2% of recurrent pterygium (P = 0.820).
61 67) in OSSN patients and 101 mum (SD, 22) in pterygium patients (P<0.001).
62                                              Pterygium recurrence 6 months after surgery ranged from
63 ective than intraoperative MMC in minimizing pterygium recurrence at the 10-year follow-up.
64   CAG was more effective than AMT to prevent pterygium recurrence by 6 months post surgery, especiall
65 duced markedly, as were flap dislocation and pterygium recurrence with Tisseel fibrin glue compared w
66      Ocular demodicosis is a risk factor for pterygium recurrence, especially for conjunctival recurr
67                                              Pterygium recurrence, patient discomfort level, and surg
68 mbrane graft surgery in reducing the rate of pterygium recurrence.
69 refractive change (SIRC), complications, and pterygium recurrence.
70 nflammation may be a new strategy to prevent pterygium recurrence.
71  surgery, no eye in the CLAU group developed pterygium recurrence; however, recurrence was seen in 2
72 dence indicates that bare sclera excision of pterygium results in a significantly higher recurrence r
73  repositioning of conjunctival autografts in pterygium surgery was associated with a similar function
74                   To evaluate the outcome of pterygium surgery with conjunctival autograft using Vicr
75                          Patients undergoing pterygium surgery with conjunctival autografting were ra
76 ive merits of the various techniques used in pterygium surgery with particular reference to the growi
77 e risk factors that influence the success of pterygium surgery.
78                                     Multiple pterygium syndrome (MPS) is a phenotypically and genetic
79   Van der Woude syndrome (VWS) and popliteal pterygium syndrome (PPS) are autosomal dominant disorder
80                                    Popliteal pterygium syndrome (PPS; OMIM 119500) is a disorder with
81 y of IRF6 causes Van der Woude and popliteal pterygium syndrome, 2 syndromic forms of cleft lip and p
82 vastating birth defects, including popliteal pterygium syndrome, cocoon syndrome, and Bartsocas-Papas
83 sorders Van der Woude syndrome and popliteal pterygium syndrome, have a hyperproliferative epidermis
84 rders Bartsocas-Papas syndrome and popliteal pterygium syndrome, respectively.
85 nderlie Van der Woude syndrome and popliteal pterygium syndrome.
86                                     Multiple pterygium syndromes (MPS) comprise a group of multiple c
87                                     Multiple pterygium syndromes (MPSs) comprise a group of multiple-
88                                              Pterygium syndromes are complex congenital disorders tha
89 individuals with Van der Woude and popliteal pterygium syndromes, suggesting that the TGFbeta/SMAD4/I
90 the cascade of molecular events that prevent pterygium syndromes.
91 as more prevalent in patients with recurrent pterygium than those with primary pterygium (P = 0.015).
92                   For 96 eyes with recurrent pterygium, the risk of recurrence 6 months after CAG was
93 protein in tears was higher in patients with pterygium versus controls.
94                The overall prevalence of any pterygium was 10.1% (n = 900), of which severe pterygium
95                                       Severe pterygium was associated with outdoor occupation (P = 0.
96                        The prevalence of any pterygium was more common in Malays (15.5%) than Chinese
97 erygium was 10.1% (n = 900), of which severe pterygium was seen in 1.6% (n = 142).
98 urrence, but the morphologic features of the pterygium were shown to affect the recurrence rate.
99 tal of 115 eyes of 114 patients with primary pterygium were treated with intraoperative MMC (n = 63)
100 ell carcinoma, 2 lymphomas, and 3 pinguecula/pterygium) while the other 30, presenting no reflectance
101 ures against UV-radiation, classification of pterygium, width of the pterygium at limbus, surgical te
102 d that race is a significant risk factor for pterygium, with Malays having higher prevalence than Ind

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top